Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

L.A. McKeown

October 17, 2025

News Daily News

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Todd Neale

July 16, 2025

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Daily News

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

Caitlin E. Cox

December 06, 2023

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Michael O'Riordan

January 28, 2021

News Daily News

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

L.A. McKeown

August 04, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Yael L. Maxwell

October 22, 2019

News Daily News

Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events

Marcus A. Banks

July 25, 2019

News Daily News

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

Caitlin E. Cox

February 27, 2019

Advertisement

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

Wider Use of Polypills to Prevent CVD Could Save Millions of Lives by 2050

Think You Need a Statin? AHA’s Risk Calculator May Disagree

AHA Celebrates a Century by Looking Back, and Forward

Top General Cardiology and CVD Prevention News of 2023

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Despite COVID-19, Heart Disease Remains Top US Killer: AHA

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content